QA: Evelo Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001694665_2023_Evelo_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001694665, Evelo Biosciences Inc.

  xvar xval
0 AssetsCurrent 51,573,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,842,000
3 remainder_Assets 8,026,000
4 LiabilitiesCurrent 12,395,000
5 LiabilitiesNoncurrent 57,038,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 29,912,000
9 ResearchAndDevelopmentExpense 78,554,000
10 remainder_Expenses 930,000
11 remainder_Revenues 0
12 remainder_NetIncome -5,131,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 64,441,000
1 Liabilities 69,433,000
2 Expenses 109,396,000
3 Revenues 0
4 StockholdersEquity -4,992,000
5 NetIncome -114,527,000
6 ComprehensiveNetIncome -114,527,000
7 BaseVar 124,200,500
8 EconomicCapitalRatio -1.84

Edgar->Model Mapping

Feature Distribution

Change over Time